Gyrodyne (NASDAQ:GYRO) specializes in managing and leasing of medical and professional office properties located predominantly in New York. The company's operations primarily involve enhancing the value of its real estate assets and optimizing rental income through diligent property management and strategic renovations. Gyrodyne aims to maximize shareholder value by potentially developing and converting its properties into residential or commercial uses, based on the evolving market demands and zoning possibilities. The core objective revolves around sustainable growth, diversifying income sources through careful asset management, and exploring opportunities for the redevelopment of its real estate portfolio to meet the highest and best uses of its properties.